ENXTPA:AKEChemicals
Arkema (ENXTPA:AKE) Stock Reprices A Margin Recovery Story
Arkema stock came into this earnings print looking beaten up, with a 90 day return that declined 5%, yet trading on just 0.5x sales and a dividend yield above 6%. That sets up a sharp expectation gap, as the market priced in margin fatigue and weak profitability. The quarter instead put profitability back at center stage.
The headline this time is earnings before interest, tax, depreciation and amortization. Arkema delivered €391m of EBITDA with a 16.1% margin and about 90 basis points of...